🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The trial investigates the efficacy and safety of brodalumab against guselk...
Status
Terminated
Location
LEO Pharma Investigational Site
Start Date
2020-12-17
Trial ID
NCT04533737
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of ustekinumab as mea...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-15
Trial ID
NCT02349061
Treatments Being Tested
This study assessed efficacy of secukinumab, compared to ustekinumab, in pa...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-02-26
Trial ID
NCT02074982
Treatments Being Tested
The purpose of this study is to establish if BMS-986202 is safe and effecti...
Status
Completed
Location
Local Institution
Start Date
2016-05-18
Trial ID
NCT02763969
Treatments Being Tested
To determine whether treatment with ustekinumab will alter the ratio of T R...
Status
Completed
Location
H. Lee Moffitt Cancer Center & Research Institute
Start Date
2013-02-25
Trial ID
NCT01713400
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of ustekinumab compar...
Status
Terminated
Location
Tokyo Medical and Dental University Hospital
Start Date
2021-09-15
Trial ID
NCT04882072
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of ustekinumab in Chi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-07-14
Trial ID
NCT04060888
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of ustekin...
Status
Completed
Location
Multiple Locations
Start Date
2015-07-10
Trial ID
NCT02407236
Treatments Being Tested
This is a randomized double blind, double dummy, placebo and active compara...
Status
Completed
Location
Multiple Locations
Start Date
2016-03
Trial ID
NCT02684357
Treatments Being Tested
The main purpose of study is to assess the dose-response relationship of BM...
Status
Completed
Location
Rheumatology Associates of North Alabama
Start Date
2019-04-01
Trial ID
NCT03881059
Treatments Being Tested